SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(van de Giessen E)
 

Search: WFRF:(van de Giessen E) > Scheltens P > Amyloid-PET and 18-...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Amyloid-PET and 18-F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

Chetelat, G. (author)
University of Caen Normandy
Arbizu, J. (author)
University Clinic of Navarra,University of Navarra
Barthel, H. (author)
University Hospital Leipzig
show more...
Garibotto, V. (author)
University of Geneva,Geneva University Hospital
Law, I. (author)
Copenhagen University Hospital
Morbelli, S. (author)
Ospedale Policlinico San Martino,University of California, Berkeley
van de Giessen, E. (author)
Academic Medical Center of University of Amsterdam (AMC),University of Amsterdam
Agosta, F. (author)
San Raffaele Scientific Institute,Vita-Salute San Raffaele University
Barkhof, F. (author)
University College London,Vrije Universiteit Amsterdam,Academic Medical Center of University of Amsterdam (AMC),University of Geneva,Geneva University Hospital
Brooks, D. J. (author)
Aarhus University Hospital,University of Newcastle upon Tyne
Carrillo, M. C. (author)
Alzheimer's Association: Alzheimer's Disease and Dementia
Dubois, B. (author)
Pitié-Salpêtrière University Hospital,Paris-Sorbonne University
Fjell, A. M. (author)
University of Oslo,Oslo university hospital
Frisoni, G. B. (author)
Hansson, Oskar (author)
Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups,Skåne University Hospital
Herholz, K. (author)
University of Manchester
Hutton, B. F. (author)
University College London
Jack, C. R. (author)
Mayo Clinic Minnesota
Lammertsma, A. A. (author)
Vrije Universiteit Amsterdam,Amsterdam UMC - Vrije Universiteit Amsterdam
Landau, S. M. (author)
University of Utah
Minoshima, S. (author)
Nobili, F. (author)
University of Genoa,Ospedale Policlinico San Martino
Nordberg, A. (author)
Karolinska Institutet,Karolinska Institute
Ossenkoppele, Rik (author)
Lund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups,Amsterdam UMC - Vrije Universiteit Amsterdam,Vrije Universiteit Amsterdam
Oyen, W. J. G. (author)
Humanitas University,Rijnstate Hospital,Humanitas Research Hospital,Radboud University Medical Center
Perani, D. (author)
San Raffaele Hospital,Vita-Salute San Raffaele University
Rabinovici, G. D. (author)
University of California, San Francisco
Scheltens, P. (author)
Vrije Universiteit Amsterdam,Amsterdam UMC - Vrije Universiteit Amsterdam
Villemagne, V. L. (author)
University of Melbourne,Austin Health,Edith Cowan University
Zetterberg, Henrik, 1973 (author)
University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Sahlgrenska University Hospital,University College London
Drzezga, A. (author)
University of Cologne,Jülich Research Centre,German Center for Neurodegenerative Diseases (DZNE), Bonn
show less...
 (creator_code:org_t)
2020
2020
English.
In: Lancet Neurology. - 1474-4422 .- 1474-4465. ; 19:11, s. 951-962
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Various biomarkers are available to support the diagnosis of neurodegenerative diseases in clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET, which assesses brain amyloid deposition, and F-18-fluorodeoxyglucose (F-18-FDG) PET, which assesses glucose metabolism, provide valuable and complementary information. However, uncertainty remains regarding the optimal timepoint, combination, and an order in which these PET biomarkers should be used in diagnostic evaluations because conclusive evidence is missing. Following an expert panel discussion, we reached an agreement on the specific use of the individual biomarkers, based on available evidence and clinical expertise. We propose a diagnostic algorithm with optimal timepoints for these PET biomarkers, also taking into account evidence from other biomarkers, for early and differential diagnosis of neurodegenerative diseases that can lead to dementia. We propose three main diagnostic pathways with distinct biomarker sequences, in which amyloid-PET and F-18-FDG-PET are placed at different positions in the order of diagnostic evaluations, depending on clinical presentation. We hope that this algorithm can support diagnostic decision making in specialist clinical settings with access to these biomarkers and might stimulate further research towards optimal diagnostic strategies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

mild cognitive impairment
progressive supranuclear palsy
cerebrospinal-fluid biomarkers
positron-emission-tomography
differential-diagnosis
clinical-diagnosis
national institute
csf
biomarkers
fdg-pet
a-beta
Neurosciences & Neurology

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view